← Back
$MIRM All transactions

Mirum Pharmaceuticals, Inc.

▼ SELL

$ Value

$1.2M

Shares

15,509

Price

$74

Filed

Sep 12

Insider

Name

Brege Laura

Title

CIK

0001365619

Roles

Director

Transaction Details

Transaction Date

2025-09-11

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

17,194

Footnotes

The weighted average sale price for the transaction reported was $74.34, and the range of prices were between $73.73 and $74.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | The weighted average sale price for the transaction reported was $75.07, and the range of prices were between $74.745 and $75.19. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | The stock option is fully vested.

Filing Info

Accession No.

0001415889-25-024463

Form Type

4

Issuer CIK

0001759425

Brege Laura's History

Date Ticker Type Value
2025-09-11 MIRM M $255K
2025-09-11 MIRM $1.2M
2025-09-11 MIRM $112K
2025-09-11 MIRM M $0
2025-06-16 EWTX A $0
2025-06-11 PCRX A $0
2025-06-11 PCRX A $0
2025-06-04 ACAD $315K
2025-05-29 ACAD M
2025-05-29 ACAD M $0

Other Insiders at MIRM (90d)

Insider Bought Sold Last
Heron Patrick J $9.0M 2026-01-23
BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER
$101K 2026-01-28
Ramasastry Saira $398K 2026-04-15
Peetz Christopher
CHIEF EXECUTIVE OFFICER
$1.6M 2026-02-02
Radovich Peter
PRESIDENT AND COO
$574K 2026-02-02
Quan Joanne
CHIEF MEDICAL OFFICER
2026-01-28
Howe Jolanda
SVP, GLOBAL CONTROLLER
$181K 2026-02-02